Results 31 to 40 of about 14,212 (288)

Facial beautification with fillers and main differences between genders [PDF]

open access: yesRevista Brasileira de Cirurgia Plástica, 2021
The beauty perception is still poorly understood, though downright remarkable. People considered beautiful notably have better self-esteem and perform better in their interpersonal relationships.
Gladstone Eustaquio de Lima Faria   +4 more
doaj   +1 more source

Hazard analysis and possibilities for preventing botulism originating from meat products [PDF]

open access: yesVeterinarski Glasnik, 2008
The paper presents the more important data on the bacteria Clostridium botulinum, the appearance of botulism, hazard analysis and the possibilities for preventing botulism.
Vasilev Dragan, Vuković Ilija
doaj   +1 more source

Dosage of botulinum toxin in patients undergoing treatment for hemifacial spasm: is there modification during follow-up?

open access: yesArquivos de Neuro-Psiquiatria
Background The movement disorder known as hemifacial spasm is characterized by involuntary contractions of the muscles that are innervated by the facial nerve. The treatment of choice for this condition is botulinum toxin injections.
Fátima de Menezes Dantas   +4 more
doaj   +1 more source

Botulinum Toxin Type a in Cervical Dystonia

open access: yesInternational Journal of Immunopathology and Pharmacology, 2012
Cervical dystonia is a syndrome characterized by anomalous postures and unintentional repetitive movements of the head and the neck. Aim of this study is to show the effectiveness of the combined treatment botulinum toxin-FKT through the use of a recent methodic of investigation, myoton, and of the classical clinical evaluations, such as Tsui and VAS ...
Marvulli R.   +7 more
openaire   +3 more sources

Uses of Botulinum Toxin in Headache and Facial Pain Disorders: An Update

open access: yesToxins
Botulinum toxin is a neurotoxin that is used in the treatments for several medical conditions, such as dystonia, spasticity, hemifacial spasm, overactive bladder, and hyperhidrosis.
Pedro Augusto Sampaio Rocha-Filho   +3 more
doaj   +1 more source

Clinical Recovery and Circulating Botulinum Toxin Type F in Adult Patient

open access: yesEmerging Infectious Diseases, 2009
A 56-year-old woman in Helena, Montana, USA, who showed clinical signs of paralysis, received antitoxins to botulinum toxins A, B, and E within 24 hours; nevertheless, symptoms progressed to complete quadriplegia. On day 8, she began moving spontaneously,
Jeremy Sobel   +5 more
doaj   +1 more source

Genetically Confirmed Schwartz–Jampel Syndrome: An Ultra-Rare Case of Congenital Myotonia with Osteochondrodysplasia from India

open access: yesInternational Journal of Medical Students
Background: Schwartz–Jampel syndrome is a rare autosomal recessive disorder caused by mutations in the HSPG2 gene, leading to perlecan deficiency. Perlecan is a heparan sulfate proteoglycan critical for cartilage integrity, basement membrane stability ...
Nandita Jali   +4 more
doaj   +1 more source

Measuring Effects on Pain and Quality of Life after Abobotulinum Toxin A Injections in Children with Cerebral Palsy

open access: yesToxins, 2022
Sixty-seven percent of children with cerebral palsy (CCP) experience pain. Pain is closely interrelated to diminished quality of life. Despite this, pain is an overlooked and undertreated clinical problem.
Christian Wong   +2 more
doaj   +1 more source

Botulinum toxin type A on cutaneous flap viability in diabetic and tobacco-exposed rats [PDF]

open access: yesActa Cirúrgica Brasileira, 2015
PURPOSE:To investigate the effect of Botulinum toxin A (BoNTA) on skin flap viability in healthy, tobacco-exposed and diabetic rats.METHODS: Ninety male Wistar rats (250-300g) were randomly divided into six groups: control+saline (C1), control+BoNTA (C2),
Cristina Pires Camargo   +7 more
doaj   +1 more source

Intravesical Injection of Botulinum Toxin Type A in Patients with Refractory Overactive Bladder—Results between Young and Elderly Populations, and Factors Associated with Unfavorable Outcomes

open access: yesToxins, 2023
Intravesical botulinum toxin type A (BoNT-A) injection has been recognized as the standard treatment for refractory overactive bladder (OAB). However, its therapeutic efficacy and safety have not been thoroughly reviewed in elderly patients.
Yin-Chien Ou   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy